# Controller Medications in the Management of Bronchial Asthma

> **NCT01055041** · NA · COMPLETED · sponsor: **Government Medical College, Bhavnagar** · enrollment: 50 (actual)

## Conditions studied

- Moderate to Severe Persistent Bronchial Asthma

## Interventions

- **DRUG:** inhaled budesonide and formeterol plus oral montelukast
- **DRUG:** inhaled budesonide and formeterol plus oral doxophylline
- **DRUG:** Doubling the dose of inhaled budesonide and formeterol

## Key facts

- **NCT ID:** NCT01055041
- **Lead sponsor:** Government Medical College, Bhavnagar
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2009-06
- **Final completion:** 2009-07
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2010-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01055041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01055041, "Controller Medications in the Management of Bronchial Asthma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01055041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*